埃斯利卡巴泽平诱导的低血:一个回顾性单中心实体临床实践研究
Ondřej Strýček1,2, Vít Všianský1, Irena Doležalová1,2
1Brno Epilepsy Center, First Department of Neurology, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Member of ERN-EpiCARE, Brno, Czech Republic.
Epilepsia open
|August 18, 2023
概括
低血症是eslicarbazepine的副作用,影响了30.5%的患者. 这种情况通常是轻微的,无症状的,并且依赖于剂量,老年是关键的危险因素.
科学领域:
- 神经学 神经学
- 药理学 药理学是指药理学的学科.
背景情况:
- 低血是已知的dibenzazepine抗发作药物的副作用之一.
- 埃斯利卡巴泽平是这个类别中常见的抗发作药物.
研究的目的:
- 为了确定治疗eslicarbazepine的患者中低血的患病率.
- 为了确定低血症的危险因素,包括剂量依赖和患者人口统计.
- 评估低血量对停止治疗的影响.
主要方法:
- 从164名患者的医疗记录进行了回顾性分析,这些患者接受了eslicarbazepine治疗.
- 评估低血的患病率,严重程度和与药物剂量相关的情况.
- 确定风险因素和停止治疗的原因.
主要成果:
- 低血的总体患病率为30.5%.
- 轻度的低血不依赖于剂量,而中度和重度的病例显著依赖于剂量.
- 老年被确定为主要风险因素;低血常常无症状,很少导致停药.
结论:
- 埃斯利卡巴泽诱导的低血是常见的,但通常是轻度和无症状的.
- 低血管理往往是不必要的,并且治疗中止是罕见的.
- 剂量和年龄较大是发生与eslicarbazepine相关的低血症的重要危险因素.
更多相关视频
相关概念视频
Antiepileptic Drugs: Potassium Channel Activators
211
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...
211
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
344
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
344
Electroconvulsive Therapy
69
Electroconvulsive therapy (ECT), or shock therapy, remains a critical biomedical intervention for severe, treatment-resistant depression. While its origins can be traced back to Hippocrates' observations that malaria-induced convulsions alleviated mental illness, modern ECT has evolved significantly from its earlier, more primitive applications. First introduced in 1938 by Ugo Cerletti and his colleagues, ECT involves inducing controlled seizures using electrical currents. In its early...
69
Antiepileptic Drugs: Calcium Channel Blockers
453
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
453
Arteries of the Lower Limbs
213
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
213
Hypertension III: Clinical Manifestations and Diagnostic Studies
26
Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
26


